Pages that link to "Q35799330"
Jump to navigation
Jump to search
The following pages link to Improving clinical benefit for prostate cancer patients through the combination of androgen deprivation and immunotherapy. (Q35799330):
Displaying 2 items.
- Prostate cancer immunotherapy, particularly in combination with androgen deprivation or radiation treatment. Customized pharmacogenomic approaches to overcome immunotherapy cancer resistance. (Q39093352) (← links)
- Identification of a Radiosensitivity Molecular Signature Induced by Enzalutamide in Hormone-sensitive and Hormone-resistant Prostate Cancer Cells. (Q64916820) (← links)